Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct-Acting Antiviral Therapy-Reference-Cited by-同舟云学术

Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct-Acting Antiviral Therapy

Published:2018-07-16 Issue:6 Volume:68 Page:2078-2088
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Alao Hawwa¹,Cam Maggie²,Keembiyehetty Chithra³,Zhang Fang¹,Serti Elisavet¹,Suarez Daniel¹,Park Heiyoung¹,Fourie Nicolaas H.⁴,Wright Elizabeth C.⁵,Henderson Wendy A.⁴,Li Qisheng¹,Liang T. Jake¹,Rehermann Barbara¹,Ghany Marc G.¹^ORCID

Affiliation:

1. Liver Diseases Branch; National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda MD

2. Office of Science and Technology Resources; National Cancer Institute; Bethesda MD

3. Genomic Core facility; National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda MD

4. Digestive Disorder Unit; National Institute of Nursing Research; Bethesda MD

5. Office of the Director, National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Bethesda MD

Funder

Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health

Intramural Research Program of NIDDK, NIH

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29921/fullpdf

Reference33 articles.

1. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection;Chen;Gastroenterology,2005

2. Lack of response to exogenous interferon-alpha in the liver of chimpanzees chronically infected with hepatitis C virus;Lanford;Hepatology,2007

3. Hepatic gene expression during treatment with peginterferon and ribavirin: identifying molecular pathways for treatment response;Feld;Hepatology,2007

4. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus;Prokunina-Olsson;Nat Genet,2013

5. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance;O'Brien;J Hepatol,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication;Clinical and Molecular Hepatology;2024-07-01

2. Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs;Hepatology Research;2024-03-27

3. Unraveling the role of the liver myeloid compartment during hepatitis C virus cure;Journal of Hepatology;2024-02

4. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents;Frontiers in Virology;2023-10-24

5. Non‐selective dampening of the host immune response after hepatitis C clearance and its association with circulating chemokine and endotoxin levels;Liver International;2023-09-26